You are here

  • Home
  • Archive
  • Volume 10, Issue 6
  • T cell repertoire in peripheral blood as a potential biomarker for predicting response to concurrent cetuximab and nivolumab in head and neck squamous cell carcinoma

Article metrics

Article menu
Immunotherapy biomarkers
Original research
T cell repertoire in peripheral blood as a potential biomarker for predicting response to concurrent cetuximab and nivolumab in head and neck squamous cell carcinoma

 

Online download statistics by month:

Online download statistics by month: June 2022 to July 2025

AbstractFullPdf
Jun 2022884905327
Jul 202238639694
Aug 202229930596
Sep 202228529488
Oct 202227327874
Nov 2022290297115
Dec 202220220348
Jan 202318719678
Feb 2023211214101
Mar 202317617676
Apr 202317317664
May 202316416985
Jun 202316817272
Jul 202319119470
Aug 202315115556
Sep 202318518558
Oct 202318818954
Nov 202318218581
Dec 202312712737
Jan 2024464723
Feb 202416416647
Mar 2024249253123
Apr 202420120370
May 202420020262
Jun 202417217257
Jul 202416917062
Aug 2024908637
Sep 2024106107166
Oct 2024108108106
Nov 202413814466
Dec 202414114345
Jan 202513914268
Feb 202519920157
Mar 202512913152
Apr 202512212236
May 2025919262
Jun 2025515244
Jul 2025110
Total723873582857